Location History:
- Kelkheim, DE (1987)
- Wiesbaden, DE (1988 - 2007)
- Wiesbaden-Naurod, DE (2007)
- Neuried, DE (2005 - 2011)
- Wuppertal, DE (2018)
- Velbert, DE (2013 - 2020)
- Werder, DE (2015 - 2024)
Company Filing History:
12 out of 6,662 
12 out of 330 
7 out of 53 
Years Active: 1987-2024
Areas of Expertise:
Title: Innovator Spotlight: Wilfried Schwab - Pioneering Pharmaceutical Formulations
Introduction:
Meet Wilfried Schwab, a prolific inventor based in Werder, Germany, who has dedicated his career to developing groundbreaking pharmaceutical formulations. With an impressive portfolio of 44 patents, Schwab continues to push the boundaries of drug stability and efficacy.
Latest Patents:
Schwab's recent patents include the crystalline mono mesylate monohydrate salt of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide. This innovation showcases specific particle size distribution and surface area ranges, resulting in enhanced long-term stability and release kinetics in pharmaceutical compositions. Additionally, his maleate salt of the free base of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide offers promising treatment options for herpes virus infections.
Career Highlights:
Throughout his career, Schwab has made significant contributions to companies like Hoechst Aktiengesellschaft and Aventis Pharma Deutschland GmbH. His expertise in pharmaceutical research and development has played a pivotal role in advancing the field of antiviral medications.
Collaborations:
Schwab has collaborated with esteemed coworkers such as Manfred Schudok and Werner Thorwart, pooling their talents to drive innovation in drug formulation. Their collective efforts have resulted in patents that hold great promise for the treatment and prevention of herpes simplex virus infections.
Conclusion:
Wilfried Schwab's dedication to pharmaceutical innovation has not only earned him a reputation as a pioneering inventor but has also paved the way for enhanced drug therapies. His commitment to advancing medical science underscores the importance of continuous innovation in tackling complex health challenges.